WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
WHO monographs on selected medicinal plants - travolekar.ru
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
F<strong>ru</strong>ctus Agni Casti<br />
the - and -receptors, while the aqueous extract was more active in the<br />
-opioid receptor. No binding in the orphan opioid receptor was noted.<br />
Rat brain striatal tissue was preincubated with 3 H-choline. Treatment<br />
of the preincubated tissue with a f<strong>ru</strong>it extract inhibited electrically stimulated<br />
release of 3 H-acetylcholine with a median inhibitory c<strong>on</strong>centrati<strong>on</strong><br />
of 30 g/ml (37). The inhibitory effect was reduced by co-incubati<strong>on</strong> of<br />
the tissues with spiroperidol. Atropine partially reduced the inhibitory<br />
effects of the f<strong>ru</strong>it extract suggesting that the extract may also work <strong>on</strong> the<br />
cholinergic receptors (37).<br />
Several extracts of chaste berry have been shown to bind to the estrogen<br />
receptor and have weak estrogenic effects, suggesting that chaste berry<br />
may also affect the estrogen/progester<strong>on</strong>e balance (43–45). A f<strong>ru</strong>it extract<br />
dose-dependently bound to both estrogen receptor isotypes, but<br />
binding appeared to be more selective for estrogen receptor than estrogen<br />
receptor (45). The extract also dose-dependently inhibited the secreti<strong>on</strong><br />
of progester<strong>on</strong>e from human granuloma cells (44), an effect that is<br />
mediated by estrogen receptor , as it can be blocked by tamoxifen. Furthermore<br />
<strong>on</strong>e in vivo study has shown that treatment of ovariectomized<br />
rats with an undefined extract of the f<strong>ru</strong>it (dose not stated) increased uterine<br />
growth, and the expressi<strong>on</strong> of uterine c-myc mRNA levels and liver<br />
ce<strong>ru</strong>loplasm mRNA levels, indicating an estrogenic effect (43).<br />
A methanol extract of the c<strong>ru</strong>de d<strong>ru</strong>g bound to both estrogen receptor<br />
and estrogen receptor , and induced the expressi<strong>on</strong> of estrogendependent<br />
genes, progester<strong>on</strong>e receptor, and pS2 (presenelin-2) in<br />
Ishikawa cells (an estrogen-dependent endometrial adenocarcinoma cell<br />
line) (45). Significant binding affinity for both estrogen receptor and<br />
estrogen receptor , with a median inhibitory c<strong>on</strong>centrati<strong>on</strong> of 46.3 μg/<br />
ml and 64.0 μg/ml, respectively, and the affinity for estrogen receptor <br />
and estrogen receptor was not significantly different (45). In Ishikawa<br />
cells, the extract exhibited weak estrogenic activity, as indicated by upregulati<strong>on</strong><br />
of the progester<strong>on</strong>e receptor mRNA; however alkaline phosphatase<br />
activity was not changed. In S30 breast cancer cells, the presenelin-2<br />
gene was up-regulated in the presence of 20.0 μg/ml of the same<br />
extract. Based <strong>on</strong> bioassay-guided isolati<strong>on</strong>, the “estrogenic” comp<strong>on</strong>ent<br />
from the f<strong>ru</strong>it extract was identified as linoleic acid, which also<br />
bound to estrogen receptor and estrogen receptor (46). Like the extract,<br />
linoleic acid also induced expressi<strong>on</strong> of the progester<strong>on</strong>e receptor<br />
mRNA in Ishikawa cells, at a c<strong>on</strong>centrati<strong>on</strong> of 1 μg/ml, indicating that<br />
binding produced a biological estrogenic effect in vitro. In additi<strong>on</strong>, low<br />
c<strong>on</strong>centrati<strong>on</strong>s of the extract or linoleic acid (10 g/ml) up-regulate the<br />
expressi<strong>on</strong> of estrogen receptor mRNA in the estrogen receptor+<br />
15